David Lovejoy
Geen lopende functies
Vermogen: 49 104 $ op 31-05-2024
Loopbaan van David Lovejoy
Eerdere bekende functies van David Lovejoy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Toronto | Corporate Officer/Principal | - | - |
| PROTAGENIC THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-02-1994 | - |
| Oprichter | 03-02-1994 | - | |
Protagenic Therapeutics, Inc. /Old/
 Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van David Lovejoy
| University of Victoria | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Canada | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Protagenic Therapeutics, Inc. /Old/
Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- David Lovejoy
- Ervaring
